JP Morgan has revised its estimates for Eurobank to reflect the acquisition of Fibank, announced on 18 November, and the €750 million capital increase.
Analysts Mehmet Sevim and Anna Zaslavskaya have raised their estimates for adjusted net earnings by 2.9% for 2027 and 6.1% for 2028. Under the new estimates, earnings will reach €1.95 billion in 2027 and €2.11 billion in 2028.
The capital increase adds 155.6 million new shares. After the resulting dilution, adjusted earnings per share fall by 1.4% in 2027 to €0.52, while in 2028 they rise by 1.6% to €0.58.
According to the investment house, Fibank’s contribution in the first year will not be enough to offset the higher share count. But in 2028, the acquisition becomes accretive to earnings per share, thanks to a full year of consolidation and some cost synergies.
Conservative assumptions
The investment house says its assumptions for the acquisition are conservative, assuming the Greek bank will take control of Fibank on 30 June 2027 with a 65% stake. This will rise to 83% following a tender offer in September 2027, with the consideration estimated at €832 million, based on the deal price. The capital increase has been factored into its models for December 2026, at a provisional price of €4.819 per share, the price on the day the transaction was announced.
JP Morgan estimates after-tax cost synergies of just €35 million in 2028, while management is targeting more than €70 million by 2029. The investment house has not factored in revenue synergies and does not assume Fibank’s cost of risk will return to normal levels, estimating its net earnings before synergies at €116 million a year in 2027 and 2028. It therefore expects the benefit to earnings per share to increase in 2029, with management estimating total accretion of about 7% with full ownership and all synergies.
Transaction costs of €10 million after tax and a restructuring cost of €90 million (€60 million in 2027 and €30 million in 2028) have also been included; these are excluded from adjusted earnings. The CET1 ratio is estimated at 13.8% for 2027-2028, compared with 14.0% before the deal. The cash payout ratio remains at 40%, with total payouts at 55% in 2027 and 57.5% in 2028.
For the US investment bank, the acquisition at 0.95 times tangible book value adds to the group’s successful acquisition track record. Together, the two banks will become Bulgaria’s largest by assets and deposits, with a market share of about 20%. The country will then account for 24%-26% of the group’s loans and net earnings.
The investment house notes that the group’s operations outside Greece already generate about half of its net earnings. It sees further upside potential from synergies at Hellenic Bank and CNP Cyprus, as well as new revenue from the acquisition of Eurolife. The resilience of the net interest margin, loan growth and fees also remain positive factors.
The shares trade at 8.1 times forecast 2028 earnings and 1.4 times tangible book value. JP Morgan forecasts average annual earnings-per-share growth of about 15% over 2026-2028, as well as a return on tangible equity of 18.4% in 2028, the highest among the Greek banks it covers.
The price target is derived using the Gordon Growth model, with a return on allocated capital of 19%, a cost of equity of 10% and a growth rate of 1%. On these assumptions, fair value is €6.34 per share. Adding €0.11 per share for excess capital gives a new price target of €6.45.